Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 869 of 1,261

  1. US 8450362

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  2. US 8450379

    Methods for treating migraine

    Corcept Therapeutics Incorporated · Granted May 28, 2013 · Expires May 23, 2033

    granted

  3. US 8450345

    Iminosugars and methods of treating viral diseases

    United Therapeutics Corporation · Granted May 28, 2013 · Expires May 23, 2033

    granted

  4. US 8450341

    Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  5. US 8450339

    Compositions for treatment of common cold

    Takeda Pharma A/S · Granted May 28, 2013 · Expires May 23, 2033

    granted

  6. US 8450323

    Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine

    Takeda Pharmaceutical Company Limited · Granted May 28, 2013 · Expires May 23, 2033

    granted

  7. US 8450337

    Methods of treating skin disorders with caffeic acid analogs

    Moleculin, LLC · Granted May 28, 2013 · Expires May 23, 2033

    granted

  8. US 8450325

    Methods for reducing the recurrence of cardiac arrhythmia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2013 · Expires May 23, 2033

    granted

  9. US 8450278

    MUC18 targeting peptides

    The Board of Regents of the University of Texas System · Granted May 28, 2013 · Expires May 23, 2033

    granted

  10. US 8450299

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  11. US 8450271

    Peptide-based scaffolds for cartilage regeneration and methods for their use

    Northwestern University · Granted May 28, 2013 · Expires May 23, 2033

    granted

  12. US 8450062

    SOCS-3 promoter methylation in cancer

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  13. US 8449876

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  14. US 8449872

    Polymer conjugates of nesiritide peptides

    Nektar Therapeutics · Granted May 28, 2013 · Expires May 23, 2033

    granted

  15. US 8449875

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  16. US 8449911

    Drug composition having active ingredient adhered at high concentration to spherical core

    Takeda Pharmaceutical Company Limited · Granted May 28, 2013 · Expires May 23, 2033

    granted

  17. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Syntonix Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  18. US 8449909

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  19. US 8450285

    Immunoregulatory peptides and methods of use

    Compass Therapeutics LLC · Granted May 28, 2013 · Expires May 23, 2033

    granted

  20. US 8449877

    Pharmaceutically purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 28, 2013 · Expires May 23, 2033

    granted

  21. US 8450055

    Malaria antigen screening method

    United States of America as represented by the Secretary of the Air Force · Granted May 28, 2013 · Expires May 23, 2033

    granted

  22. US 8450321

    6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    GILEAD CONNECTICUT, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  23. US 8449890

    Neprilysin inhibitors

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  24. US 8450481

    Compounds for inhibiting protein aggregation, and methods for making and using them

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.